Prostavue clinical trials

Prospective Study of Added Value of Florastamin (18F) PET/CT in Localisation of Clinically Significant Prostate Cancer in Patients with PI- Report of Multi-Parametric MRI, Elevated Serum PSA Levels and/or PSA Density and with Clinical Suspicion of Prostate Cancer

This study is looking at a new imaging test, called Prostavue, for men who might have prostate cancer. It wants to see how well Prostavue can find prostate cancer and help doctors decide on the best treatment plan.